Eli Lilly and Company
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
Agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platform INDIANAPOLIS, Nov. 6, 2026 — Eli Lilly…
Company newsroom
NYSE:LLY · NYSE:HIMS
1 releases
Agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platform INDIANAPOLIS, Nov. 6, 2026 — Eli Lilly…